Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
DarioHealth Corp (DRIO)
NASDAQ:DRIO
DarioHealth (DRIO) Stock Price & Analysis
232 Followers
DRIO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.68 - $4.58
Previous Close$1.46
Volume63.41K
Average Volume (3M)126.42K
Market Cap
$42.99M
Enterprise Value$29.03M
Total Cash (Recent Filing)$43.88M
Total Debt (Recent Filing)$29.92M
Price to Earnings (P/E)-0.7
Beta1.38
Next Earnings
May 13, 2024EPS Estimate
-$0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.96
Shares Outstanding29,442,532
10 Day Avg. Volume104,587
30 Day Avg. Volume126,419
Standard Deviation0.27
R-Squared0.11
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.11
Price to Sales (P/S)1.55
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.76
Enterprise Value/Gross Profit3.01
Enterprise Value/Ebitda-0.61
Forecast
1Y Price Target
$4.83Price Target Upside217.76% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
DarioHealth News
PremiumCompany Announcements
DarioHealth Raises CFO Zvi Ben-David’s Salary and Bonus Potential
PremiumPre-Earnings
Is DRIO a Buy, Before Earnings?
PremiumCompany Announcements
DarioHealth Corp Unveils Updated Investor Presentation
PremiumCompany Announcements
DarioHealth Corp Welcomes New COO, Eyes Strategic ExpansionOwnership Overview
24.94% Insiders
2.20% Mutual Funds
1.46% Other Institutional Investors
71.41% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DRIO FAQ
What was DarioHealth Corp’s price range in the past 12 months?
DarioHealth Corp lowest stock price was $0.68 and its highest was $4.58 in the past 12 months.
What is DarioHealth Corp’s market cap?
Currently, no data Available
When is DarioHealth Corp’s upcoming earnings report date?
DarioHealth Corp’s upcoming earnings report date is May 13, 2024 which is in 10 days.
How were DarioHealth Corp’s earnings last quarter?
DarioHealth Corp released its earnings results on Mar 28, 2024. The company reported -$0.41 earnings per share for the quarter, missing the consensus estimate of -$0.39 by -$0.02.
Is DarioHealth Corp overvalued?
According to Wall Street analysts DarioHealth Corp’s price is currently Undervalued.
Does DarioHealth Corp pay dividends?
DarioHealth Corp does not currently pay dividends.
What is DarioHealth Corp’s EPS estimate?
DarioHealth Corp’s EPS estimate is -$0.3.
How many shares outstanding does DarioHealth Corp have?
DarioHealth Corp has 29,442,532 shares outstanding.
What happened to DarioHealth Corp’s price movement after its last earnings report?
DarioHealth Corp reported an EPS of -$0.41 in its last earnings report, missing expectations of -$0.39. Following the earnings report the stock price went up 0.658%.
Which hedge fund is a major shareholder of DarioHealth Corp?
Among the largest hedge funds holding DarioHealth Corp’s share is Perceptive Advisors LLC. It holds DarioHealth Corp’s shares valued at N/A.
---
DarioHealth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.83 (217.76% Upside)
$4.83 (217.76% Upside)
Blogger Sentiment
Bullish
DRIO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 313.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.1%
Last 30 Days ▲ 31.5%
Last 30 Days ▲ 31.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-54.79%
12-Months-Change
Fundamentals
Return on Equity
-79.57%
Trailing 12-Months
Asset Growth
-19.13%
Trailing 12-Months
Company Description
DarioHealth Corp
DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.
---
DRIO Earnings Call
Q4 2024
0:00 / 0:00
---
DRIO Stock 12 Months Forecast
Average Price Target
$4.83
▲(217.76% Upside)
Technical Analysis
Best Analysts Covering DRIO
1 Year
1 Year Success Rate
1/9 ratings generated profit
1 Year Average Return
-35.07%
reiterated a buy rating last month
Copying David Grossman's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -35.07% per trade.
---